1. A phase II study of carboplatin and pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer. (2016) Authors: Nishizawa, Hironari; Horiike, Atsushi; Saito, Ryota; Ohyanagi, Fumiyoshi; Kudo, Keita; Yanagitani, Noriko; Tambo, Yuichi; Kitazono, Satoru; Kobayashi, Hiroshi; Nishio, Makoto Journal: Cancer treatment and research communications Issue: Number 9(2016) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment. (June 2020) Authors: Tozuka, Takehiro; Kitazono, Satoru; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Uematsu, Shinya; Yoshizawa, Takahiro; Hasegawa, Tsukasa; Ariyasu, Ryo; Uchibori, Ken; Yanagitani, Noriko; Horai, Takeshi; Seike, Masahiro; Gemma, Akihiko; Nishio, Makoto Journal: Lung cancer Issue: Volume 144(2020) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients. (2020) Authors: Tozuka, Takehiro; Yanagitani, Noriko; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Uematsu, Shinya; Yoshizawa, Takahiro; Hasegawa, Tsukasa; Ariyasu, Ryo; Uchibori, Ken; Kitazono, Satoru; Seike, Masahiro; Gemma, Akihiko; Nishio, Makoto Journal: Cancer treatment and research communications Issue: Number 25(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients. Issue 10 (19th August 2019) Authors: Kitazono, Satoru; Sakai, Kazuko; Yanagitani, Noriko; Ariyasu, Ryo; Yoshizawa, Takahiro; Dotsu, Yosuke; Koyama, Junji; Saiki, Masafumi; Sonoda, Tomoaki; Nishikawa, Shingo; Uchibori, Ken; Horiike, Atsushi; Nishio, Kazuto; Nishio, Makoto Journal: Cancer science Issue: Volume 110:Issue 10(2019) Page Start: 3350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib. Issue 6 (7th May 2021) Authors: Sakamoto, Hiroaki; Yanagitani, Noriko; Manabe, Ryo; Tsugitomi, Ryosuke; Ogusu, Shinsuke; Tozuka, Takehiro; Yoshida, Hiroshi; Amino, Yoshiaki; Ariyasu, Ryo; Uchibori, Ken; Kitazono, Satoru; Tasaka, Sadatomo; Nishio, Makoto Journal: Cancer reports Issue: Volume 4:Issue 6(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021‐01). Issue 2 (21st November 2022) Authors: Uematsu, Shinya; Kitazono, Satoru; Tanaka, Hisashi; Saito, Ryota; Kawashima, Yosuke; Ohyanagi, Fumiyoshi; Tozuka, Takehiro; Ryosuke, Tsugitomi; Sakatani, Toshio; Horiike, Atsushi; Yoshizawa, Takahiro; Saiki, Masafumi; Tambo, Yuichi; Koyama, Junji; Kanazu, Masaki; Kudo, Keita; Tsuchiya‐Kawano, Yuk... Journal: Thoracic cancer Issue: Volume 14:Issue 2(2023) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020‐02). Issue 10 (12th April 2022) Authors: Tanaka, Hisashi; Sakamoto, Hiroaki; Akita, Takahiro; Ohyanagi, Fumiyoshi; Kawashima, Yosuke; Tambo, Yuichi; Tanimoto, Azusa; Horiike, Atsushi; Miyauchi, Eisaku; Tsuchiya‐Kawano, Yuko; Yanagitani, Noriko; Nishio, Makoto Journal: Thoracic cancer Issue: Volume 13:Issue 10(2022) Page Start: 1471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2. Issue 6 (2nd February 2021) Authors: Uchibori, Ken; Takano, Natsuki; Manabe, Ryo; Tsugitomi, Ryosuke; Ogusu, Shinsuke; Tozuka, Takehiro; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Ariyasu, Ryo; Kitazono, Satoru; Yanagitani, Noriko; Nishio, Makoto Journal: Thoracic cancer Issue: Volume 12:Issue 6(2021) Page Start: 906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody. (July 2019) Authors: Saiki, Masafumi; Yoshizawa, Takahiro; Dotsu, Yosuke; Ariyasu, Ryo; Koyama, Junji; Sonoda, Tomoaki; Uchibori, Ken; Nishikawa, Shingo; Kitazono, Satoru; Yanagitani, Noriko; Horiike, Atsushi; Nishio, Makoto Journal: Lung cancer Issue: Volume 133(2019) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor. Issue 9 (1st July 2013) Authors: Sakai, Kazuko; Horiike, Atsushi; Irwin, Darryl L.; Kudo, Keita; Fujita, Yoshihiko; Tanimoto, Azusa; Sakatani, Toshio; Saito, Ryota; Kaburaki, Kyohei; Yanagitani, Noriko; Ohyanagi, Fumiyoshi; Nishio, Makoto; Nishio, Kazuto Journal: Cancer science Issue: Volume 104:Issue 9(2013:Sep.) Page Start: 1198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗